Development of an Alamar Blue™ viability assay in 384-well format for high throughput whole cell screening of Trypanosoma brucei brucei bloodstream form strain 427

American Journal of Tropical Medicine and Hygiene

Volumn 81, Issue 4, 2009, Pages 665-674

  Sykes, Melissa L ^a   Avery, Vicky M ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; DIMINAZENE ACETURATE; PENTAMIDINE; REAGENT;

AFRICAN TRYPANOSOMIASIS; ARTICLE; CELL ASSAY; CELL DENSITY; CELL GROWTH; CELL SCREENING; CELL VIABILITY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG SENSITIVITY; HIGH THROUGHPUT SCREENING; IC 50; IN VITRO STUDY; NONHUMAN; TRYPANOSOMA BRUCEI;

ANIMALS; DIMINAZENE; HUMANS; INDICATORS AND REAGENTS; OXAZINES; PENTAMIDINE; SENSITIVITY AND SPECIFICITY; SPHINGOSINE; STAINING AND LABELING; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; XANTHENES;

TRYPANOSOMA BRUCEI BRUCEI;

EID: 70349755775     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.09-0015     Document Type: Article

References (26)

1. World Health Organization, 2006. Human African trypanosomiasis (sleeping sickness): epidemiological update. Wkly Epidemiol Rec 81: 71-80.
2. Moore AC, 2005. Prospects for improving African trypanosomiasis chemotherapy. J Infect Dis 191: 1793-1795.
3. Brun R, Schumacher R, Schmid C, Kunz C, Burri C, 2001. The phenomenon of treatment failures in human African trypanosomiasis. Trop Med Int Health 6: 906-914. (Pubitemid 33010877)
4. Chappuis F, Udayraj N, Stietenroth K, Meussen A, Bovier PA, 2005. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis. Clin Infect Dis 41: 748-751. (Pubitemid 41170365)
5. Pink R, Hudson A, Mouries MA, Bendig M, 2005. Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov 4: 727-740. (Pubitemid 43090494)
6. Mackey ZB, Baca AM, Mallari JP, Apsel B, Shelat A, Hansell EJ, Chiang PK, Wolff B, Guy KR, Williams J, McKerrow JH, 2006. Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chem Biol Drug Des 67: 355-363. (Pubitemid 43910068)
7. Martyn DC, Jones DC, Fairlamb AH, Clardy J, 2007. High-throughput screening affords novel and selective trypanothione reductase inhibitors with antitrypanosomal activity. Bioorg Med Chem Lett 17: 1280-1283. (Pubitemid 46240853)
8. O'Brien J, Wilson I, Orton T, Pognan F, 2000. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267: 5421-5426. (Pubitemid 30679258)
9. Bienen EJ, Webster P, Fish WR, 1991. Trypanosoma (Nannomonas) congolense: changes in respiratory metabolism during the life cycle. Exp Parasitol 73: 403-412.
10. Raz B, Iten M, Grether-Buhler Y, Kaminsky R, Brun R, 1997. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T. b. rhodesiense and T. b. gambiense) in vitro. Acta Trop 68: 139-147. (Pubitemid 27438330)
11. Lanteri CA, Stewart ML, Brock JM, Alibu VP, Meshnick SR, Tidwell RR, Barrett MP, 2006. Roles for the Trypanosoma brucei P2 transporter in DB75 uptake and resistance. Mol Pharmacol 70: 1585-1592.
12. Stewart ML, Boussard C, Brun R, Gilbert IH, Barrett MP, 2005. Interaction of monobenzamidine-linked trypanocides with the Trypanosoma brucei P2 aminopurine transporter. Antimicrob Agents Chemother 49: 5169-5171. (Pubitemid 41778944)
13. Merschjohann K, Steverding D, 2006. In vitro growth inhibition of bloodstream forms of Trypanosoma brucei and Trypanosoma congolense by iron chelators. Kinetoplastid Biol Dis 5: 3.
14. Rifkin MR, 1978. Identification of the trypanocidal factor in normal human serum: high density lipoprotein. Proc Natl Acad Sci USA 75: 3450-3454.
15. Damper D, Patton CL, 1976. Pentamidine transport and sensitivity in Brucei-group trypanosomes. J Protozool 23: 349-356.
16. Hoet S, Opperdoes F, Brun R, Adjakidje V, Quetin-Leclercq J, 2004. In vitro antitrypanosomal activity of ethnopharmacologically selected Beninese plants. J Ethnopharmacol 91: 37-42.
17. Klenke B, Stewart M, Barrett MP, Brun R, Gilbert IH, 2001. Synthesis and biological evaluation of s-triazine substituted polyamines as potential new anti-trypanosomal drugs. J Med Chem 44: 3440-3452. (Pubitemid 32947910)
18. Zhang JH, Chung TD, Oldenburg KR, 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4: 67-73.
19. Iversen PW, Eastwood BJ, Sittampalam GS, Cox KL, 2006. A comparison of assay performance measures in screening assays: signal window, Z′ factor, and assay variability ratio. J Biomol Screen 11: 247-252.
20. Sui Y, Wu Z, 2007. Alternative statistical parameter for high-throughput screening assay quality assessment. J Biomol Screen 12: 229-234. (Pubitemid 46364419)
21. Hirumi H, Hirumi K, 1989. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. J Parasitol 75: 985-989. (Pubitemid 20099178)
22. Seethala R, Fernandes PB, Ebooks Corporation, 2001. Handbook of Drug Screening. New York: Marcel Dekker, 15.
23. Graham SV, Wymer B, Barry JD, 1998. Activity of a trypanosome metacyclic variant surface glycoprotein gene promoter is dependent upon life cycle stage and chromosomal context. Mol Cell Biol 18: 1137-1146. (Pubitemid 28100877)
24. Even MS, Sandusky CB, Barnard ND. 2006. Serum-free hybridoma culture: ethical, scientific and safety considerations. Trends Biotechnol 24: 105-108.
25. Bohets HH, Nouwen EJ, De Broend ME, Dierickx PJ, 1994. Effects of foetal calf serum on cell viability, cytotoxicity and detoxification in the two kidney-derived cell lines LLC-PK 1 and MDCK. Toxicol In Vitro 8: 559-561. (Pubitemid 24312727)
26. Hamid R, Rotshteyn Y, Rabadi L, Parikh R, Bullock P, 2004. Comparison of Alamar blue and MTT assays for high throughput screening. Toxicol In Vitro 18: 703-710. (Pubitemid 38900879)